ReviewNigerian medical journal : journal of the Nigeria Medical Association
High-Risk Cervical Human Papillomavirus Prevalence in a Northeast Nigeria Community: A Descriptive Study.
Review in Nigerian medical journal : journal of the Nigeria Medical Association. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Disparities in cervical screening result in disproportionate cervical cancer burdens in populations. This study assessed cervical human papillomavirus (HPV) infection prevalence in a rural northeast Nigeria community with low access to cervical screening. Methodology: A community health outreach was conducted at a primary healthcare facility in Azare, Bauchi State, Nigeria. The women who wished to and consented to undergo gynaecological consultations were non-randomly enrolled on the study and provided their sociodemographic data and cervical specimens (Pap smear and cytobrush exfoliates in viral transport media) for the study. These were analysed cytologically and for the presence of HPV deoxyribonucleic acid (DNA). Results: Of 62 women screened (mean age 38.5 ± 9.8 years), 34 (54.8%) tested positive for HPV DNA (95% confidence interval = 43-67%). Among these positive cases, 19 had no intraepithelial lesion or malignancy (NILM), 8 were designated atypical squamous cell of undetermined significance (ASCUS), and 6 showed low-grade squamous intraepithelial lesion (LSIL). In contrast, one case was high-grade SIL (HSIL). Thirty single infections were seen, HPV 16 being the commonest (18 cases), followed by HPV 18 (9 cases), while non-16, non-18 genotypes (genotypes 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 67, 68), collectively termed "Others", accounted for 3 cases. Coinfections among different genotype classes (genotypes 16, 18 and Others) occurred in 4 additional cases. Most of the women had a primary education or higher (43; 69.4%), were married (53; 85.5%), and were multiparous (52; 83.9%). However, the majority had not heard about cervical cancer (35; 56.5%), while 60 (96.8%) women had never been screened previously. Conclusions: The results suggest a high prevalence of cervical HR-HPV and SIL in Azare. Improved public enlightenment and access to cervical cancer screening services may help to decrease transmission of HPV and subsequent cervical cancer in the population.
Indexed as
Identifiers
42471877PMC13379845What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.